Grants for Small businesses - Federal

The Federal and State Technology (FAST) Partnership Program provides funding to organizations to execute state/regional programs that increase the number of SBIR/STTR proposals leading to an increase in the number of SBIR/STTR awards from women, socially/economically disadvantaged individuals, and small businesses in underrepresented areas - typically rural states.

This grant provides funding to various organizations and businesses to promote and expand direct marketing opportunities for local agricultural products, benefiting farmers and communities across the U.S.

This funding opportunity provides financial support for the development of affordable and culturally appropriate biomedical technologies aimed at reducing healthcare disparities among underserved populations in the United States.

The U.S. Department of State, Bureau of Democracy, Human Rights, and Labor (DRL) announces an open competition for organizations interested in submitting applications for a project that supports the meaningful political and civic participation of youth in the Solomon Islands.

U.S. Embassy Mexico City of the U.S. Department of State announces an open competition for organizations to submit applications to carry out a program to promote workforce development in the printed circuit board (PCB) industry through curriculum development for PCB focused courses at secondary and tertiary educational levels, certificate programs, vocational instruction, dual education, technical English language skills building, and full or partial support for internships in Taiwanese PCB manufacturing firms either in Taiwan or Mexico.

This funding opportunity provides financial support to U.S.-based small businesses and academic researchers for the discovery and development of small molecule drugs targeting disorders of the nervous system.

This funding opportunity provides financial support for workshops that unite experts to tackle challenges in connecting genetic data with observable traits in agriculture, promoting innovation and collaboration among researchers, industry, and stakeholders.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and the National Institute of Neurological Disorders and Stroke (NINDS), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and National Heart, Lung and Blood Institute (NHLBI), intend to publish a Notice of Funding Opportunity (NOFO) to solicit applications for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRCs). These Centers promote collaborative basic, translational, and clinical research and provide important resources that can be used by the national muscular dystrophy research communities. The Centers also provide outstanding environments for the training of new researchers capable of addressing high priority objectives in muscular dystrophy research. Center investigators are expected to participate in important community outreach efforts to increase awareness of their research activities among people with lived experience and the related advocacy communities and to incorporate community perspectives into the conduct of patient-centered research. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. Only New and Renewal applications will be eligible. This NOFO will utilize the P50 activity code. Details of the planned NOFO are provided below.

This funding opportunity provides financial support to organizations that create long-term safe homes and comprehensive care for women and girls who have experienced sexual exploitation and trafficking.

This funding opportunity provides financial support for diverse organizations to develop and evaluate strategies that improve access to treatment and care for individuals with opioid use disorder, particularly focusing on overcoming barriers in healthcare settings.

This grant provides funding for collaborative projects between academic institutions and industry partners to develop and validate innovative technologies for disease diagnosis and treatment.

This funding opportunity supports U.S. small businesses in collaboration with research institutions to develop innovative technologies that improve health outcomes through research and commercialization.

This funding opportunity supports early-career researchers who have recently completed their doctoral or clinical training, allowing them to launch independent research projects without the need for preliminary data.

This funding opportunity supports researchers in sociology to conduct innovative studies that deepen our understanding of social behavior, institutions, and structures across various topics.

This funding opportunity provides financial support for researchers to conduct innovative analyses of existing HIV/AIDS data and specimen collections, focusing on improving health outcomes for mothers, children, and adolescents.

This grant provides funding for researchers and organizations to develop and test innovative strategies to prevent and address the effects of prenatal alcohol exposure and Fetal Alcohol Spectrum Disorders.

This funding opportunity supports U.S. organizations in developing innovative genomic technologies and methods to improve the diagnosis of rare genetic diseases through comprehensive data generation and integration.

This grant provides funding for researchers exploring how people learn and enhance their cognitive abilities through technology and collaboration, with a focus on interdisciplinary studies that connect various levels of analysis.

This funding opportunity supports innovative research projects aimed at improving the diagnosis of rare genetic diseases through advanced genomic technologies and analytical methods.

This funding opportunity provides financial support to small businesses that have previously received federal Phase II awards, helping them advance cancer-related technologies toward commercialization through partnerships with investors.